Work

US Government Spending on New Drugs With Incomplete and Postponed Mandatory Pediatric Trials

Year: 2025

Type: article

Abstract: This cohort study estimates Medicare Part D, Medicaid, and Medicare Part B spending on pediatric drugs approved by the US Food and Drug Administration from 2015 to 2021.

Source: Archives of Pediatrics and Adolescent Medicine

DOI: 10.1001/jamapediatrics.2025.2817

Authors: Ian T. T. Liu, Aaron S. Kesselheim

Institutions: Brigham and Women's Hospital, Harvard University, University of Illinois Chicago

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4413914629

FWCI: 2.918

Cites: 3

Cited by: 3

Related to: 10